• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

了解静脉血栓栓塞症治疗中患者的护理障碍。

Understanding patients' care barriers in the treatment of venous thromboembolism.

机构信息

Department of Pharmacotherapy, University of Utah, 30 South, 2000 East, Rm #4323, Salt Lake City, UT, 84112-5820, USA.

Kantar LLC, San Francisco, CA, USA.

出版信息

J Thromb Thrombolysis. 2019 Jul;48(1):35-41. doi: 10.1007/s11239-019-01880-3.

DOI:10.1007/s11239-019-01880-3
PMID:31102162
Abstract

Venous thromboembolism (VTE) is a major health care problem. There are common barriers to quality healthcare but are these barriers the same for VTE patients? A national online survey was administered to adults who had experienced a recent VTE event. The survey assessed perceptions of VTE care barriers: (1) Difficulty to meet healthcare costs related to VTE care; (2) difficulty to meet costs for VTE prescription medications; (3) difficulty with transportation to get VTE care; and (4) the degree of support of others needed to get VTE care. Each question was correlated with patient demographics including income level, place of residence, current work status, and health insurance; care related patient harms experienced with the VTE episode; number of lifetime VTE events; beliefs concerning VTE outcomes, and oral anticoagulant therapy type. Logistic regression analysis was used to determine the effect of independent variables on barriers to VTE care. Approximately 30% of VTE patients reported at least one significant barrier to VTE care. Patients rated healthcare costs and VTE prescription medication costs mildly difficult. The odds of reporting barriers were positively associated with the number of DVTs experienced in the previous 2 years. VTE-related depression was also moderately associated with increased odds of reporting significant VTE care barriers. Nearly 1 in 3 VTE sufferers reported significant barriers to VTE care, with healthcare costs and VTE medication costs being the most common. Efforts to identify patients who may experience barriers should be sought early in care.

摘要

静脉血栓栓塞症(VTE)是一个主要的医疗保健问题。医疗保健质量存在共同的障碍,但这些障碍对 VTE 患者是否相同?一项针对经历过近期 VTE 事件的成年人的全国在线调查。该调查评估了对 VTE 护理障碍的看法:(1)难以承担与 VTE 护理相关的医疗费用;(2)难以支付 VTE 处方药物的费用;(3)获得 VTE 护理的交通困难;(4)获得 VTE 护理所需的他人支持程度。每个问题都与患者的人口统计学特征相关,包括收入水平、居住地、当前工作状况和医疗保险;与 VTE 发作相关的护理相关伤害;一生中 VTE 事件的次数;对 VTE 结果的信念,以及口服抗凝剂治疗类型。逻辑回归分析用于确定独立变量对 VTE 护理障碍的影响。大约 30%的 VTE 患者报告至少存在一个 VTE 护理的重大障碍。患者认为医疗费用和 VTE 处方药物费用略有困难。在过去 2 年内经历 DVT 次数越多,报告障碍的几率就越高。VTE 相关的抑郁也与报告显著 VTE 护理障碍的几率增加呈中度相关。近 1/3 的 VTE 患者报告存在 VTE 护理的重大障碍,其中医疗费用和 VTE 药物费用是最常见的障碍。应尽早在护理中寻找可能遇到障碍的患者。

相似文献

1
Understanding patients' care barriers in the treatment of venous thromboembolism.了解静脉血栓栓塞症治疗中患者的护理障碍。
J Thromb Thrombolysis. 2019 Jul;48(1):35-41. doi: 10.1007/s11239-019-01880-3.
2
Prevalence and correlates of bleeding and emotional harms in a national US sample of patients with venous thromboembolism: A cross-sectional structural equation model.在美国静脉血栓栓塞患者的全国样本中,出血和情绪伤害的流行情况及其相关性:一项横断面结构方程模型研究。
Thromb Res. 2018 Dec;172:181-187. doi: 10.1016/j.thromres.2018.05.025. Epub 2018 May 23.
3
Patient Satisfaction With Venous Thromboembolism Treatment.患者对静脉血栓栓塞症治疗的满意度。
Clin Appl Thromb Hemost. 2019 Jan-Dec;25:1076029619864663. doi: 10.1177/1076029619864663.
4
Is Adherence to the American College of Chest Physicians Recommended Anticoagulation Treatment Duration Associated With Different Outcomes Among Patients With Venous Thromboembolism?对于静脉血栓栓塞症患者,遵循美国胸科医师学会推荐的抗凝治疗持续时间是否与不同结局相关?
Clin Appl Thromb Hemost. 2017 Sep;23(6):532-541. doi: 10.1177/1076029616680475. Epub 2016 Nov 30.
5
The economic burden of incident venous thromboembolism in the United States: A review of estimated attributable healthcare costs.美国新发静脉血栓栓塞症的经济负担:对估计的可归因医疗费用的综述。
Thromb Res. 2016 Jan;137:3-10. doi: 10.1016/j.thromres.2015.11.033. Epub 2015 Nov 24.
6
Risks and cost burden of venous thromboembolism and bleeding for patients undergoing total hip or knee replacement in a managed-care population.在管理式医疗人群中,接受全髋关节或全膝关节置换术的患者发生静脉血栓栓塞和出血的风险及费用负担。
J Med Econ. 2011;14(3):324-34. doi: 10.3111/13696998.2011.578698. Epub 2011 Apr 20.
7
Healthcare costs associated with rivaroxaban or warfarin use for the treatment of venous thromboembolism.与使用利伐沙班或华法林治疗静脉血栓栓塞相关的医疗费用。
J Med Econ. 2017 Feb;20(2):200-203. doi: 10.1080/13696998.2016.1243544. Epub 2016 Oct 26.
8
Long term risk of symptomatic recurrent venous thromboembolism after discontinuation of anticoagulant treatment for first unprovoked venous thromboembolism event: systematic review and meta-analysis.首次无诱因静脉血栓栓塞事件停止抗凝治疗后症状性复发性静脉血栓栓塞的长期风险:系统评价和荟萃分析。
BMJ. 2019 Jul 24;366:l4363. doi: 10.1136/bmj.l4363.
9
Healthcare resource utilization and costs associated with venous thromboembolism recurrence in patients with cancer.癌症患者静脉血栓栓塞复发相关的医疗资源利用和成本
J Med Econ. 2020 Apr;23(4):323-329. doi: 10.1080/13696998.2019.1703190. Epub 2020 Jan 11.
10
Transition of care for patients with venous thromboembolism: Rationale, design and implementation of a quality intervention project conducted at American Thrombosis and Hemostasis Network (ATHN) affiliated sites.静脉血栓栓塞症患者的治疗过渡期:在美国血栓与止血网络(ATHN)附属站点开展的一项质量干预项目的原理、设计和实施。
Thromb Res. 2018 Mar;163:146-152. doi: 10.1016/j.thromres.2018.01.043. Epub 2018 Feb 2.

引用本文的文献

1
Health Literacy and Treatment Satisfaction Among Patients with Venous Thromboembolism.静脉血栓栓塞症患者的健康素养和治疗满意度。
J Gen Intern Med. 2023 May;38(7):1585-1592. doi: 10.1007/s11606-022-07852-3. Epub 2022 Nov 3.
2
A descriptive study of antithrombotic medication patterns in adult patients with recent venous thromboembolism.近期发生静脉血栓栓塞的成年患者抗血栓药物使用模式的描述性研究。
Pharm Pract (Granada). 2019 Jul-Sep;17(3):1539. doi: 10.18549/PharmPract.2019.3.1539. Epub 2019 Aug 22.

本文引用的文献

1
Perceived Mental Healthcare Barriers and Health-seeking Behavior of African-American Caregivers of Adolescents with Mental Health Disorders.非裔美国青少年心理健康障碍护理者感知的精神卫生保健障碍和寻医行为。
Issues Ment Health Nurs. 2019 Jul;40(7):585-592. doi: 10.1080/01612840.2018.1547803. Epub 2019 Mar 27.
2
Secondary prophylaxis decision-making in venous thromboembolism: interviews on clinical practice in thirteen countries.静脉血栓栓塞症的二级预防决策:对13个国家临床实践的访谈
Res Pract Thromb Haemost. 2017 Jun 20;1(1):41-48. doi: 10.1002/rth2.12014. eCollection 2017 Jul.
3
Locus of control and pain: Validity of the Form C of the Multidimensional Health Locus of Control scales when used with adolescents.
控制点与疼痛:多维健康控制源量表 C 式在青少年群体中的适用性:效度验证。
J Health Psychol. 2018 Dec;23(14):1853-1862. doi: 10.1177/1359105316669860. Epub 2016 Sep 28.
4
Guidance for the treatment of deep vein thrombosis and pulmonary embolism.深静脉血栓形成和肺栓塞的治疗指南。
J Thromb Thrombolysis. 2016 Jan;41(1):32-67. doi: 10.1007/s11239-015-1317-0.
5
Strategies to enhance venous thromboprophylaxis in hospitalized medical patients (SENTRY): a pilot cluster randomized trial.增强住院内科患者静脉血栓栓塞症预防策略(SENTRY):一项试点性集群随机试验。
Implement Sci. 2013 Jan 2;8:1. doi: 10.1186/1748-5908-8-1.
6
Challenges in implementing government-directed VTE guidance for medical patients: a mixed methods study.实施政府主导的医疗患者静脉血栓栓塞症防治指南面临的挑战:一项混合方法研究。
BMJ Open. 2012 Nov 6;2(6). doi: 10.1136/bmjopen-2012-001668. Print 2012.
7
Barriers to the diagnosis and treatment of venous thromboembolism in advanced cancer patients: a qualitative study.晚期癌症患者静脉血栓栓塞症诊断和治疗障碍的定性研究。
Palliat Med. 2013 Apr;27(4):339-48. doi: 10.1177/0269216312461678. Epub 2012 Oct 23.
8
Nonfinancial barriers and access to care for U.S. adults.美国成年人的非财务障碍与医疗保健可及性。
Health Serv Res. 2012 Feb;47(1 Pt 2):462-85. doi: 10.1111/j.1475-6773.2011.01308.x. Epub 2011 Aug 22.
9
Patient perceptions of mistakes in ambulatory care.患者对门诊医疗中失误的认知。
Arch Intern Med. 2010 Sep 13;170(16):1480-7. doi: 10.1001/archinternmed.2010.288.
10
Venous thromboembolism: a public health concern.静脉血栓栓塞症:公共健康关注点。
Am J Prev Med. 2010 Apr;38(4 Suppl):S495-501. doi: 10.1016/j.amepre.2009.12.017.